Cargando…
Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry
The host proteins SERINC3 and SERINC5 are HIV-1 restriction factors that reduce infectivity when incorporated into the viral envelope. The HIV-1 accessory protein Nef abrogates incorporation of SERINCs via binding to intracellular loop 4 (ICL4). Here, we determine cryoEM maps of full-length human SE...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359404/ https://www.ncbi.nlm.nih.gov/pubmed/37474505 http://dx.doi.org/10.1038/s41467-023-39262-2 |
_version_ | 1785075874128723968 |
---|---|
author | Leonhardt, Susan A. Purdy, Michael D. Grover, Jonathan R. Yang, Ziwei Poulos, Sandra McIntire, William E. Tatham, Elizabeth A. Erramilli, Satchal K. Nosol, Kamil Lai, Kin Kui Ding, Shilei Lu, Maolin Uchil, Pradeep D. Finzi, Andrés Rein, Alan Kossiakoff, Anthony A. Mothes, Walther Yeager, Mark |
author_facet | Leonhardt, Susan A. Purdy, Michael D. Grover, Jonathan R. Yang, Ziwei Poulos, Sandra McIntire, William E. Tatham, Elizabeth A. Erramilli, Satchal K. Nosol, Kamil Lai, Kin Kui Ding, Shilei Lu, Maolin Uchil, Pradeep D. Finzi, Andrés Rein, Alan Kossiakoff, Anthony A. Mothes, Walther Yeager, Mark |
author_sort | Leonhardt, Susan A. |
collection | PubMed |
description | The host proteins SERINC3 and SERINC5 are HIV-1 restriction factors that reduce infectivity when incorporated into the viral envelope. The HIV-1 accessory protein Nef abrogates incorporation of SERINCs via binding to intracellular loop 4 (ICL4). Here, we determine cryoEM maps of full-length human SERINC3 and an ICL4 deletion construct, which reveal that hSERINC3 is comprised of two α-helical bundles connected by a ~ 40-residue, highly tilted, “crossmember” helix. The design resembles non-ATP-dependent lipid transporters. Consistently, purified hSERINCs reconstituted into proteoliposomes induce flipping of phosphatidylserine (PS), phosphatidylethanolamine and phosphatidylcholine. Furthermore, SERINC3, SERINC5 and the scramblase TMEM16F expose PS on the surface of HIV-1 and reduce infectivity, with similar results in MLV. SERINC effects in HIV-1 and MLV are counteracted by Nef and GlycoGag, respectively. Our results demonstrate that SERINCs are membrane transporters that flip lipids, resulting in a loss of membrane asymmetry that is strongly correlated with changes in Env conformation and loss of infectivity. |
format | Online Article Text |
id | pubmed-10359404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-103594042023-07-22 Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry Leonhardt, Susan A. Purdy, Michael D. Grover, Jonathan R. Yang, Ziwei Poulos, Sandra McIntire, William E. Tatham, Elizabeth A. Erramilli, Satchal K. Nosol, Kamil Lai, Kin Kui Ding, Shilei Lu, Maolin Uchil, Pradeep D. Finzi, Andrés Rein, Alan Kossiakoff, Anthony A. Mothes, Walther Yeager, Mark Nat Commun Article The host proteins SERINC3 and SERINC5 are HIV-1 restriction factors that reduce infectivity when incorporated into the viral envelope. The HIV-1 accessory protein Nef abrogates incorporation of SERINCs via binding to intracellular loop 4 (ICL4). Here, we determine cryoEM maps of full-length human SERINC3 and an ICL4 deletion construct, which reveal that hSERINC3 is comprised of two α-helical bundles connected by a ~ 40-residue, highly tilted, “crossmember” helix. The design resembles non-ATP-dependent lipid transporters. Consistently, purified hSERINCs reconstituted into proteoliposomes induce flipping of phosphatidylserine (PS), phosphatidylethanolamine and phosphatidylcholine. Furthermore, SERINC3, SERINC5 and the scramblase TMEM16F expose PS on the surface of HIV-1 and reduce infectivity, with similar results in MLV. SERINC effects in HIV-1 and MLV are counteracted by Nef and GlycoGag, respectively. Our results demonstrate that SERINCs are membrane transporters that flip lipids, resulting in a loss of membrane asymmetry that is strongly correlated with changes in Env conformation and loss of infectivity. Nature Publishing Group UK 2023-07-20 /pmc/articles/PMC10359404/ /pubmed/37474505 http://dx.doi.org/10.1038/s41467-023-39262-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Leonhardt, Susan A. Purdy, Michael D. Grover, Jonathan R. Yang, Ziwei Poulos, Sandra McIntire, William E. Tatham, Elizabeth A. Erramilli, Satchal K. Nosol, Kamil Lai, Kin Kui Ding, Shilei Lu, Maolin Uchil, Pradeep D. Finzi, Andrés Rein, Alan Kossiakoff, Anthony A. Mothes, Walther Yeager, Mark Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry |
title | Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry |
title_full | Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry |
title_fullStr | Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry |
title_full_unstemmed | Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry |
title_short | Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry |
title_sort | antiviral hiv-1 serinc restriction factors disrupt virus membrane asymmetry |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359404/ https://www.ncbi.nlm.nih.gov/pubmed/37474505 http://dx.doi.org/10.1038/s41467-023-39262-2 |
work_keys_str_mv | AT leonhardtsusana antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT purdymichaeld antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT groverjonathanr antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT yangziwei antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT poulossandra antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT mcintirewilliame antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT tathamelizabetha antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT erramillisatchalk antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT nosolkamil antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT laikinkui antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT dingshilei antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT lumaolin antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT uchilpradeepd antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT finziandres antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT reinalan antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT kossiakoffanthonya antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT motheswalther antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry AT yeagermark antiviralhiv1serincrestrictionfactorsdisruptvirusmembraneasymmetry |